IBRX
ImmunityBioANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
IBRX vs peer average
80/100
IBRX vs. peer average (A vs. C)
Grade spread
A 1 · B 3 · C 2 · D 4
Graded peers loaded
Coverage
10 graded
91% of tracked
Peer overview
AUPH is the first available peer comparator.
Closest size-matched commercial biopharma comparator in the packet; useful for judging whether IBRX can convert a single marketed specialty asset into durable revenue and narrower financing risk.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IBRX
ImmunityBio
AUPH
Aurinia
Grade
A
B
Momentum
91
48
Value
41
65
Sentiment
54
57
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs AUPH
IBRX / AUPH
Grade Position
Above peers
IBRX vs. peer average (A vs. C)
80/100
Momentum
91
IBRXValue
41
AUPHSentiment
54
AUPHRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IBRX
AUPH is the first peer returned for this comparison set.

